← Back to Search

Pulse Oximetry Calibration for Hypoxia

N/A
Waitlist Available
Research Sponsored by Rhythm Diagnostic Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is 18 to 50 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from device placement to device removal, assessed up to 3 hours
Awards & highlights

Study Summary

This trial will test a device to measure blood oxygen levels in healthy adults of all skin tones, from light to dark. Data from the device will be compared to a gold-standard reference, to meet FDA guidelines.

Who is the study for?
Healthy adults aged 18-50, non-smokers or those who haven't smoked in the last 2 days. Participants must have a range of skin tones, including at least three with dark pigmentation. They should be able to follow study procedures and give written consent. Excluded are morbidly obese individuals, pregnant women, people with certain health conditions like heart issues or severe allergies to sensor materials.Check my eligibility
What is being tested?
The trial is testing the MultiSense® pulse oximetry system's accuracy in measuring oxygen saturation (SpO2) during non-motion conditions against a reference system. It involves subjects with varying skin pigmentations and uses induced hypoxic levels to evaluate performance.See study design
What are the potential side effects?
There may not be direct side effects from participating as this is a device calibration study; however, discomfort from wearing the device on the thorax or potential skin irritation from adhesives used for attaching sensors could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from device placement to device removal, assessed up to 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and from device placement to device removal, assessed up to 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determination of the quality of measurements of arterial blood saturation (SpO2) provided by the MultiSense® system in comparison to measurements made with a reference Pulse Oximetry System, in terms of accuracy.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Controled Hypoxia - Healthy volunteerExperimental Treatment1 Intervention
Male and female subjects, ranging in pigmentation from light to dark

Find a Location

Who is running the clinical trial?

Rhythm Diagnostic SystemsLead Sponsor
5 Previous Clinical Trials
171 Total Patients Enrolled
2 Trials studying Hypoxia
28 Patients Enrolled for Hypoxia
Clinimark, LLCOTHER
21 Previous Clinical Trials
973 Total Patients Enrolled
8 Trials studying Hypoxia
577 Patients Enrolled for Hypoxia

Media Library

Controled Hypoxia - Healthy volunteer Clinical Trial Eligibility Overview. Trial Name: NCT05466942 — N/A
Hypoxia Research Study Groups: Controled Hypoxia - Healthy volunteer
Hypoxia Clinical Trial 2023: Controled Hypoxia - Healthy volunteer Highlights & Side Effects. Trial Name: NCT05466942 — N/A
Controled Hypoxia - Healthy volunteer 2023 Treatment Timeline for Medical Study. Trial Name: NCT05466942 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the current research encompass participants aged over twenty?

"Those hoping to enroll in this clinical trial must meet the criteria of being between 18 and 50 years old. There are alternative trials offered for those younger than eighteen, as well as 86 trials available specifically for seniors over 65."

Answered by AI

Who can be accepted into this trial as a participant?

"To qualify for this clinical trial, applicants should have hypoxia and lie between the ages 18-50. The total participant count is limited to 16 individuals."

Answered by AI

Are individuals being recruited for this clinical experiment at present?

"The data hosted on clinicaltrials.gov indicates that this medical trial is no longer actively seeking participants, with the initial posting being made in March 15th 2022 and its last edit occurring a year later. However, 142 other studies are currently recruiting patients to participate.."

Answered by AI
~5 spots leftby Apr 2025